INSIGHTS ON QUALITY ASSURANCE

• Modernizing Biopharma Manufacturers To Improve Quality And Safety

  Read how proven, scalable digital solutions to modernize pharmaceutical product innovation and development gives enterprises an edge in meeting the manufacturing guidelines for pharmaceuticals while elevating the entire industry.

• How Effective Training Management Can Help You Prevent Quality Issues

  Training defines the quality of the single most important asset of your organization: your employees. A good training management process serves as a preventative measure against poor quality.

• Speed To Market – API Large-Scale Commercial Manufacturing

  A pharmaceutical company was looking to partner with a CMO with commercial manufacturing capabilities, large-scale assets, multinational sites, and exemplary quality systems/U.S. FDA track record.

• Time Is Money: The Hidden Cost Of Inefficient Laboratory Practices

  Explore an overview of the main inventory management challenges faced by fast-paced biotech and pharmaceutical laboratories that highlights how this directly impacts research outcomes, costs, and regulatory compliance.

• Clarifying Confusion In Quality Assurance, Control, And Management Systems

  3/24/2022

  With similar-sounding terminologies, it’s easy to misinterpret their definitions and purposes. Here we demystify the roles of each quality function, ways they differ, and impact on one another.

• 3 Reasons Life Sciences Should Adopt A Data-Centric Quality Mindset

  2/16/2022

  So few are poised to adopt a data-centric approach by using digitization, analytics, and AI that those who do will reap benefits from the data in their now unstructured documents.

• FDA Remote “Inspections” During The Pandemic

  3/24/2022

  Remote inspections can be easy if the company being audited has invested in a quality management system that stores its documents, provides version control, and tracks all changes.

• Quality With Clarity: Bringing Modern Quality Systems Into Focus

  8/24/2021

  Modern pharmaceutical regulatory and manufacturing models have made great advances assuring and confirming quality of products for all of us. The further industry moves from the initial application of the early practices and subsequent systems, the more challenging it has become to differentiate between the many facets of quality concepts. The intent of this white paper is to clarify those concepts and bring their fundamentals into focus.

• How Much Money, Time, Effort Is Paper Costing Drug Manufacturers?

  9/26/2022

  We explore the true cost of paper for pharma manufacturing and explain why digital transformation for pharma companies is here to stay.